faillisted in Coinbase#752 by calls of 844 on this host
0.005 USDC
per call, as the listing declares it on eip155:
- Validation state
- fail
- Uptime, 7 / 30 / 90 days
- 43% / 83% / 83%
- Calls, trailing 30 days
- 3
- Unique payers, trailing 30 days
- 1
- Last called
- 2026-10-12 13:35 UTC
- First observed by TOLLderived
- 2026-09-28
- Pricederived
- 0.005 USDC
- Networks
- 1
How has the volume on this endpoint moved?
The sweep of 2026-10-20 found calc hfa icos myeloma unreachable.
calc hfa icos myeloma, a POST endpoint on api.magentlab.com, appears in the Coinbase registry; TOLL's taxonomy puts it in search.
On Base, calc hfa icos myeloma asks 0.005 USDC per call.
Callers of calc hfa icos myeloma supply a JSON body with the field items.
A response from calc hfa icos myeloma, as declared, includes path, count and items.
One payer accounts for all 3 calls to calc hfa icos myeloma over 30 days.
The last call to calc hfa icos myeloma came 1 day before the snapshot, 2026-10-12.
Of api.magentlab.com's 844 listings, calc hfa icos myeloma ranks tied 752nd by calls with 92 others.
Among comparable prices in search, calc hfa icos myeloma sits above 24% of them.
Closest in price to calc hfa icos myeloma within search: search at twitter.use.x402atlas.com and search at api.you.com.
The wallet paid by calc hfa icos myeloma is the payee of 844 endpoints on one host.
calc hfa icos myeloma out-counts 51% of the 2,591 endpoints in search that carry counters.
Seller tags: hfa-icos, myeloma, cardio-oncology and hemodynamics.
calc hfa icos myeloma dropped out of the registry at the pull of 2026-09-30 and was listed again on 2026-09-30.
The price of calc hfa icos myeloma is declared by 365 other listings in search too.
the payment options, as of 2026-10-13 14:08 UTC · method · pinnable
| registry | network | asset | amount | scheme | pay to |
|---|---|---|---|---|---|
| Coinbase | eip155: | USDC | 0.005 USDC | exact | 0x836Be2…c19Ee2 |
the checks, as of 2026-10-20 11:29 UTC · method · pinnableendpoint answered HTTP none
endpoint_reachable· the endpoint answered at all
Every sweep that observed this endpoint, newest first.
| observed, UTC | state | failed checks | sweep |
|---|---|---|---|
| 2026-10-20 11:29 UTC | fail | 1 | daily-2026-10-20 |
| 2026-10-19 09:08 UTC | fail | 1 | daily-2026-10-19 |
| 2026-10-18 10:59 UTC | fail | 1 | daily-2026-10-18 |
| 2026-10-17 21:24 UTC | fail | 1 | daily-2026-10-17 |
| 2026-10-16 07:11 UTC | pass | 0 | daily-2026-10-16 |
| 2026-10-15 08:58 UTC | pass | 0 | daily-2026-10-15 |
| 2026-10-14 07:00 UTC | pass | 0 | daily-2026-10-14 |
| 2026-10-13 11:45 UTC | pass | 0 | daily-2026-10-13 |
| 2026-10-12 09:06 UTC | pass | 0 | daily-2026-10-12 |
| 2026-10-11 07:49 UTC | pass | 0 | daily-2026-10-11 |
| 2026-10-10 15:56 UTC | pass | 0 | daily-2026-10-10 |
| 2026-10-09 08:40 UTC | pass | 0 | daily-2026-10-09 |
| 2026-10-08 10:09 UTC | pass | 0 | daily-2026-10-08 |
| 2026-10-07 09:32 UTC | pass | 0 | daily-2026-10-07 |
| 2026-10-06 10:18 UTC | pass | 0 | daily-2026-10-06 |
| 2026-10-05 09:13 UTC | pass | 0 | daily-2026-10-05 |
| 2026-10-04 11:30 UTC | pass | 0 | daily-2026-10-04 |
| 2026-10-03 06:10 UTC | pass | 0 | daily-2026-10-03 |
| 2026-10-02 15:23 UTC | pass | 0 | daily-2026-10-02 |
| 2026-10-01 08:13 UTC | pass | 0 | daily-2026-10-01 |
| 2026-09-30 07:35 UTC | pass | 0 | daily-2026-09-30 |
| 2026-09-29 19:49 UTC | pass | 0 | daily-2026-09-29 |
| 2026-09-28 16:58 UTC | pass | 0 | daily-2026-09-28 |
| 2026-09-28 16:44 UTC | pass | 0 | new-after-daily-2026-09-28 |
Presence in a registry, not liveness of the service (method). Newest first.
- back in Coinbase
- absent from Coinbase at this pull
- listed in Coinbase
From the registry record, not validated by TOLL.the declared schema, as of 2026-10-12 13:35 UTC · method · live
The input and output block
{
"input": {
"body": {
"items": [
{
"ckd": false,
"obesity": false,
"diabetes": false,
"age_years": 50,
"arrhythmia": false,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"hyperlipidemia": false,
"elevated_troponin": false,
"venous_thrombosis": false,
"cardiac_amyloidosis": false,
"prior_anthracycline": false,
"high_dose_dexamethasone": false,
"arterial_vascular_disease": false,
"family_history_thrombophilia": false,
"left_ventricular_hypertrophy": false,
"current_or_significant_smoker": false,
"heart_failure_or_cardiomyopathy": false,
"prior_thoracic_spine_radiotherapy": false,
"prior_immunomodulatory_drug_cv_toxicity": false,
"prior_proteasome_inhibitor_cardiotoxicity": false
},
{
"ckd": false,
"obesity": false,
"diabetes": false,
"age_years": 50,
"arrhythmia": false,
"elevated_bnp": false,
"hypertension": false,
"lvef_percent": 60,
"hyperlipidemia": false,
"elevated_troponin": false,
"venous_thrombosis": false,
"cardiac_amyloidosis": false,
"prior_anthracycline": false,
"high_dose_dexamethasone": false,
"arterial_vascular_disease": false,
"family_history_thrombophilia": false,
"left_ventricular_hypertrophy": false,
"current_or_significant_smoker": false,
"heart_failure_or_cardiomyopathy": false,
"prior_thoracic_spine_radiotherapy": false,
"prior_immunomodulatory_drug_cv_toxicity": false,
"prior_proteasome_inhibitor_cardiotoxicity": false
}
]
},
"type": "http",
"method": "POST"
},
"output": {
"type": "json",
"example": {
"path": "/api/calc/hfa_icos_myeloma",
"count": 2,
"items": [
{
"formula": "hfa_icos_myeloma",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "prior_proteasome_inhibitor_cardiotoxicity",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "venous_thrombosis",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "cardiac_amyloidosis",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "arterial_vascular_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_immunomodulatory_drug_cv_toxicity",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_anthracycline",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "arrhythmia",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "left_ventricular_hypertrophy",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hyperlipidemia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "family_history_thrombophilia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "prior_thoracic_spine_radiotherapy",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "high_dose_dexamethasone",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 50,
"factor": "age_years",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 60,
"factor": "lvef_percent",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"lvef_percent": 60,
"medium_points": 0,
"formula_expression": "very_high if any Very high factor (heart_failure_or_cardiomyopathy, prior_proteasome_inhibitor_cardiotoxicity, venous_thrombosis, cardiac_amyloidosis, arterial_vascular_disease); else high if any High factor (prior_immunomodulatory_drug_cv_toxicity, lvef_percent<50, elevated_bnp, age_years>=75, prior_anthracycline) OR medium_points>=5; else medium if medium_points in 2..4; else low (no factors or one Medium 1). medium_points sums Medium 1 (=1: left_ventricular_hypertrophy, age_years 65-74, hypertension, diabetes, hyperlipidemia, ckd, family_history_thrombophilia, prior_thoracic_spine_radiotherapy, high_dose_dexamethasone, current_or_significant_smoker, obesity) and Medium 2 (=2: lvef_percent 50-54, arrhythmia, elevated_troponin) only. Age and LVEF use the highest matching printed band. Lyon 2020 HFA-ICOS multiple-myeloma therapy table. cardiotoxicity_guide is that paper's expert-opinion guide: low <2%, medium 2-9%, high 10-19%, very high >=20%",
"cardiotoxicity_guide": "<2%"
},
{
"formula": "hfa_icos_myeloma",
"citation": {
"id": "lyon-2020",
"doi": "10.1002/ejhf.1920",
"pmid": "32458582",
"title": "Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society",
"source": "Eur J Heart Fail. 2020;22(11):1945-1960",
"authors": "Lyon AR, Dent S, Stanway S, et al."
},
"age_years": 50,
"components": [
{
"tier": "very_high",
"factor": "heart_failure_or_cardiomyopathy",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "prior_proteasome_inhibitor_cardiotoxicity",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "venous_thrombosis",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "cardiac_amyloidosis",
"points": 0,
"present": false
},
{
"tier": "very_high",
"factor": "arterial_vascular_disease",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_immunomodulatory_drug_cv_toxicity",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "elevated_bnp",
"points": 0,
"present": false
},
{
"tier": "high",
"factor": "prior_anthracycline",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "arrhythmia",
"points": 0,
"present": false
},
{
"tier": "medium_2",
"factor": "elevated_troponin",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "left_ventricular_hypertrophy",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hypertension",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "diabetes",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "hyperlipidemia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "ckd",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "family_history_thrombophilia",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "prior_thoracic_spine_radiotherapy",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "high_dose_dexamethasone",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "current_or_significant_smoker",
"points": 0,
"present": false
},
{
"tier": "medium_1",
"factor": "obesity",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 50,
"factor": "age_years",
"points": 0,
"present": false
},
{
"tier": "none",
"value": 60,
"factor": "lvef_percent",
"points": 0,
"present": false
}
],
"disclaimer": "Not a medical device. Deterministic published-formula or published-code output for autonomous agents. A licensed clinician remains responsible for patient care and billing submissions.",
"risk_level": "low",
"lvef_percent": 60,
"medium_points": 0,
"formula_expression": "very_high if any Very high factor (heart_failure_or_cardiomyopathy, prior_proteasome_inhibitor_cardiotoxicity, venous_thrombosis, cardiac_amyloidosis, arterial_vascular_disease); else high if any High factor (prior_immunomodulatory_drug_cv_toxicity, lvef_percent<50, elevated_bnp, age_years>=75, prior_anthracycline) OR medium_points>=5; else medium if medium_points in 2..4; else low (no factors or one Medium 1). medium_points sums Medium 1 (=1: left_ventricular_hypertrophy, age_years 65-74, hypertension, diabetes, hyperlipidemia, ckd, family_history_thrombophilia, prior_thoracic_spine_radiotherapy, high_dose_dexamethasone, current_or_significant_smoker, obesity) and Medium 2 (=2: lvef_percent 50-54, arrhythmia, elevated_troponin) only. Age and LVEF use the highest matching printed band. Lyon 2020 HFA-ICOS multiple-myeloma therapy table. cardiotoxicity_guide is that paper's expert-opinion guide: low <2%, medium 2-9%, high 10-19%, very high >=20%",
"cardiotoxicity_guide": "<2%"
}
]
}
}
}Cite this page
The pinned URL below renders this page from the snapshot of 2026-10-13 14:08 UTC and does not change; the live page does, every six hours. Data reuse is under CC BY 4.0 (terms).
Plain text
TOLL, "calc hfa icos myeloma on api.magentlab.com", snapshot of 2026-10-13 14:08 UTC. https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-myeloma-7faddb/at/2026-10-13T14-08Z. Accessed [access date].
BibTeX
@misc{toll-e-api-magentlab-com-api-calc-hfa-icos-myeloma-7faddb-2026-10-13T14-08Z,
author = {TOLL},
title = {calc hfa icos myeloma on api.magentlab.com},
howpublished = {\url{https://tollindex.com/e/api-magentlab-com-api-calc-hfa-icos-myeloma-7faddb/at/2026-10-13T14-08Z}},
year = {2026},
month = {10},
note = {Pinned view of the snapshot of 2026-10-13 14:08 UTC. Accessed [access date].}
}None yet. Anything submitted through the form below is published here with its outcome.